Answers are grounded in this paper and cite their sources.
Editors note: The above letter was referred to the authors of the original article, and their reply follows. In reply: Our research team welcomes the letter from Dr. de la Vega because the respondent reiterates and further elaborates on several important points made in our paper. The Health Risk Appraisal questionnaire is intended to elicit self-reported disease symptomatology for the purposes of risk assessment and is not conceptualized as a diagnostic instrument. Thus, the items used to characterize the fluid imbalance symptoms of CHF may not be specific for CHF alone. However, the relationship between nocturnal incontinence and these symptoms suggests that this problem is complex and requires further attention by health care providers and research investigators alike. While we referenced the reported use of DDAVP for nocturia in older adults, we do not agree or suggest that DDAVP is necessarily an appropriate treatment for nocturnal enuresis in this population, nor do our data support the use of this treatment. Rather, our data clearly support the need for more work on the pattern and regulation of urine production in older adults and to examine the effects of various disease processes. We specifically point out that treatments must be developed that are appropriate to individual underlying abnormalities of bladder function and fluid balance without overlooking the possibility of underlying congestive heart failure or reversible circumstances such as the patient's use of sleep medications.
No takes yet. Share an insight, caveat, or question.
Burgio et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: